$ARWR
ARROWHEAD PHARMACEUTICALS, INC.

2022 Q1 Form 10-Q Financial Statement

#000156459022019275 Filed on May 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $151.8M $32.81M
YoY Change 362.68% 39.45%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $33.86M $16.19M
YoY Change 109.16% 0.12%
% of Gross Profit
Research & Development $73.80M $44.70M
YoY Change 65.12% 58.39%
% of Gross Profit
Depreciation & Amortization $2.594M $1.500M
YoY Change 72.93% 66.67%
% of Gross Profit
Operating Expenses $110.3M $61.04M
YoY Change 80.61% 33.37%
Operating Profit $41.55M
YoY Change
Interest Expense $1.054M $1.520M
YoY Change -30.66% -36.67%
% of Operating Profit 2.54%
Other Income/Expense, Net $1.759M -$110.0K
YoY Change -1699.09%
Pretax Income $44.37M -$26.82M
YoY Change -265.42% 35.18%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $44.37M -$26.82M
YoY Change -265.43% 35.2%
Net Earnings / Revenue 29.23% -81.74%
Basic Earnings Per Share $0.42
Diluted Earnings Per Share $411.1K -$258.2K
COMMON SHARES
Basic Shares Outstanding 105.5M shares
Diluted Shares Outstanding 107.9M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $401.9M $498.2M
YoY Change -19.33% 61.96%
Cash & Equivalents $86.40M $372.4M
Short-Term Investments $315.5M $125.8M
Other Short-Term Assets $14.42M $8.400M
YoY Change 71.64% 50.0%
Inventory
Prepaid Expenses
Receivables $1.317M $1.000M
Other Receivables $0.00 $0.00
Total Short-Term Assets $417.6M $586.8M
YoY Change -28.82% 86.57%
LONG-TERM ASSETS
Property, Plant & Equipment $71.27M $39.40M
YoY Change 80.88% 34.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $201.6M $97.50M
YoY Change 106.76% -48.85%
Other Assets $275.0K $300.0K
YoY Change -8.33% 200.0%
Total Long-Term Assets $285.9M $170.0M
YoY Change 68.16% -31.05%
TOTAL ASSETS
Total Short-Term Assets $417.6M $586.8M
Total Long-Term Assets $285.9M $170.0M
Total Assets $703.6M $756.8M
YoY Change -7.03% 34.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.60M $5.300M
YoY Change 100.06% -60.45%
Accrued Expenses $30.39M $17.00M
YoY Change 78.74% 153.73%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $138.9M $167.2M
YoY Change -16.95% 213.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $112.5M $144.1M
YoY Change -21.96% 914.79%
Total Long-Term Liabilities $112.5M $144.1M
YoY Change -21.96% 914.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $138.9M $167.2M
Total Long-Term Liabilities $112.5M $144.1M
Total Liabilities $251.3M $311.2M
YoY Change -19.25% 364.48%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $452.3M $445.5M
YoY Change
Total Liabilities & Shareholders Equity $703.6M $756.8M
YoY Change -7.03% 34.88%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $44.37M -$26.82M
YoY Change -265.43% 35.2%
Depreciation, Depletion And Amortization $2.594M $1.500M
YoY Change 72.93% 66.67%
Cash From Operating Activities $62.73M $263.9M
YoY Change -76.23% -1056.16%
INVESTING ACTIVITIES
Capital Expenditures -$4.752M -$7.100M
YoY Change -33.07% 97.22%
Acquisitions
YoY Change
Other Investing Activities -$65.00M -$26.90M
YoY Change 141.65% -84.58%
Cash From Investing Activities -$69.76M -$34.10M
YoY Change 104.56% -80.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.846M 2.600M
YoY Change -29.0% 100.0%
NET CHANGE
Cash From Operating Activities 62.73M 263.9M
Cash From Investing Activities -69.76M -34.10M
Cash From Financing Activities 1.846M 2.600M
Net Change In Cash -5.179M 232.4M
YoY Change -102.23% -213.7%
FREE CASH FLOW
Cash From Operating Activities $62.73M $263.9M
Capital Expenditures -$4.752M -$7.100M
Free Cash Flow $67.48M $271.0M
YoY Change -75.1% -1229.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.004
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.866
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.006
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.904
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
110252000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
41553000
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1054000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1759000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-110000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7734000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
84000
us-gaap Profit Loss
ProfitLoss
-47550000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
372560000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
44366000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
452266000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
445549000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
408822000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
58306000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3682000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-38000
us-gaap Profit Loss
ProfitLoss
-18506000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-4153000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
773000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-329000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8938000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
109000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7914000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2213000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-54926000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.41
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
247118000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1383000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10530000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
148391000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
40000000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
55781000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
47545000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3892000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3731000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7735000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-98026000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
228794000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
184434000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
143583000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
86408000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
372377000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86400000
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7900000
CY2022Q1 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
192900000
CY2022Q1 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
201600000
arwr Increase Decrease In Cash And Investments
IncreaseDecreaseInCashAndInvestments
9900000
CY2022Q1 arwr Computers Software Office Equipment And Furniture Gross
ComputersSoftwareOfficeEquipmentAndFurnitureGross
2272000
CY2021Q3 arwr Computers Software Office Equipment And Furniture Gross
ComputersSoftwareOfficeEquipmentAndFurnitureGross
2170000
CY2022Q1 arwr Research Equipment Gross
ResearchEquipmentGross
28370000
CY2022Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
6414000
CY2021Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
345000
CY2022Q1 us-gaap Land
Land
2996000
CY2022Q1 arwr Cash Equivalents Held To Maturity And Marketable Securities Amortized Cost
CashEquivalentsHeldToMaturityAndMarketableSecuritiesAmortizedCost
549985000
CY2022Q1 arwr Cash Equivalents Held To Maturity And Marketable Securities Gross Unrealized Gains
CashEquivalentsHeldToMaturityAndMarketableSecuritiesGrossUnrealizedGains
226000
CY2022Q1 arwr Cash Equivalents Held To Maturity And Marketable Securities Gross Unrealized Losses
CashEquivalentsHeldToMaturityAndMarketableSecuritiesGrossUnrealizedLosses
12402000
CY2022Q1 arwr Cash Equivalents Held To Maturity And Marketable Securities Fair Value
CashEquivalentsHeldToMaturityAndMarketableSecuritiesFairValue
537809000
CY2021Q3 arwr Cash Equivalents Held To Maturity And Marketable Securities Amortized Cost
CashEquivalentsHeldToMaturityAndMarketableSecuritiesAmortizedCost
429703000
CY2021Q3 arwr Cash Equivalents Held To Maturity And Marketable Securities Gross Unrealized Gains
CashEquivalentsHeldToMaturityAndMarketableSecuritiesGrossUnrealizedGains
1954000
CY2021Q3 arwr Cash Equivalents Held To Maturity And Marketable Securities Gross Unrealized Losses
CashEquivalentsHeldToMaturityAndMarketableSecuritiesGrossUnrealizedLosses
856000
CY2021Q3 arwr Cash Equivalents Held To Maturity And Marketable Securities Fair Value
CashEquivalentsHeldToMaturityAndMarketableSecuritiesFairValue
430801000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
61820
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
44.77
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
444764
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
900000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
900000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1700000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1700000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1700000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1700000
CY2022Q1 arwr Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
5200000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13663000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
850000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
12813000
CY2022Q1 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
150000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
105702499
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.28
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2949655
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
20.78
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y4M24D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
83259543
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2342356
CY2022Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1300000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1100000
us-gaap Operating Lease Cost
OperatingLeaseCost
2600000
us-gaap Operating Lease Cost
OperatingLeaseCost
2000000.0
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
100000
CY2021Q1 us-gaap Variable Lease Cost
VariableLeaseCost
200000
us-gaap Variable Lease Cost
VariableLeaseCost
300000
us-gaap Variable Lease Cost
VariableLeaseCost
500000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
0
us-gaap Short Term Lease Cost
ShortTermLeaseCost
0
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0
CY2021Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2537000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4786000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4621000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4749000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5050000
CY2022Q1 arwr Lessee Operating Lease Liability Payments Due Year Five And After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
13200000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
34943000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
9335000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
25608000
us-gaap Operating Lease Payments
OperatingLeasePayments
2200000
us-gaap Operating Lease Payments
OperatingLeasePayments
1400000
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y7M6D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.085
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3456239
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.60
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
75982912
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
At vesting, each outstanding RSU will be exchanged for one share of the Company’s Common Stock. RSU awards generally vest subject to the satisfaction of service requirements or the satisfaction of both service requirements and achievement of certain performance targets.  

Files In Submission

Name View Source Status
0001564590-22-019275-index-headers.html Edgar Link pending
0001564590-22-019275-index.html Edgar Link pending
0001564590-22-019275.txt Edgar Link pending
0001564590-22-019275-xbrl.zip Edgar Link pending
arwr-10q_20220331.htm Edgar Link pending
arwr-10q_20220331_htm.xml Edgar Link completed
arwr-20220331.xsd Edgar Link pending
arwr-20220331_cal.xml Edgar Link unprocessable
arwr-20220331_def.xml Edgar Link unprocessable
arwr-20220331_lab.xml Edgar Link unprocessable
arwr-20220331_pre.xml Edgar Link unprocessable
arwr-ex101_473.htm Edgar Link pending
arwr-ex311_10.htm Edgar Link pending
arwr-ex312_7.htm Edgar Link pending
arwr-ex321_11.htm Edgar Link pending
arwr-ex322_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending